RECRUITING · OBSERVATIONAL · Rare Diseases · Enrollment 450 · Sponsor: AstraZeneca
Official title: A Multicenter Non Interventional Single Arm Retrospective-prospective Observational Study in Therapeutic Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis (gMG) in Real Clinical Practice in Russia
Summary: This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.
Conditions: Rare Diseases, Generalized Myasthenia Gravis (gMG)
Study type: OBSERVATIONAL
Enrollment: 450 (ESTIMATED)
Status: RECRUITING
Completion: 2029-12-31 (ESTIMATED)